{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T13:03:34Z","timestamp":1773234214160,"version":"3.50.1"},"reference-count":16,"publisher":"American Academy of Pediatrics (AAP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,2,1]]},"abstract":"<jats:p>Iatrogenic Cushing\u2019s syndrome (CS) is a severe adverse effect of systemic glucocorticoid (GC) therapy in children, but is extremely rare in the setting of topical ocular GC therapy. In this article, we report the case of a 9-year-old girl suffering from idiopathic uveitis who developed CS due to topical ocular GC treatment. She was referred to the ophthalmology department with a complaint of painful eyes, at which time she was diagnosed with bilateral iridocyclitis and started on a treatment of betamethasone sodium phosphate eye drops. Six months after the initiation of topical ocular GC treatment, she was referred to our pediatric department with stunted growth, truncal obesity, purple skin striate, buffalo hump, and moon face. Because her serum cortisol and plasma adrenocorticotropic hormone levels were undetectable, she was diagnosed with iatrogenic CS. After the doses of topical ocular GC were reduced, the clinical symptoms of CS were improved. The fact that the amount of topical ocular GC with our patient was apparently less than that of similar previous cases tempted us to perform genetic analysis of her NR3C1 gene. We found that our patient had a single heterozygous nucleotide substitution in the 3\u2032 untranslated region of the NR3C1 gene, which may explain why she developed CS. However, additional investigations are required to determine if our findings can be extrapolated to other patients. In conclusion, clinicians should be aware that even extremely low doses of topical ocular steroid therapy can cause iatrogenic CS.<\/jats:p>","DOI":"10.1542\/peds.2016-1233","type":"journal-article","created":{"date-parts":[[2017,1,19]],"date-time":"2017-01-19T12:19:58Z","timestamp":1484828398000},"source":"Crossref","is-referenced-by-count":15,"title":["Iatrogenic Cushing\u2019s Syndrome Due to Topical Ocular Glucocorticoid Treatment"],"prefix":"10.1542","volume":"139","author":[{"given":"Daisuke","family":"Fukuhara","sequence":"first","affiliation":[{"name":"Departments of Pediatrics, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihiko","family":"Takiura","sequence":"additional","affiliation":[{"name":"Departments of Pediatrics, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Keino","sequence":"additional","affiliation":[{"name":"Ophthalmology, Kyorin University School of Medicine, Mitaka, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annabelle A.","family":"Okada","sequence":"additional","affiliation":[{"name":"Ophthalmology, Kyorin University School of Medicine, Mitaka, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunimasa","family":"Yan","sequence":"additional","affiliation":[{"name":"Departments of Pediatrics, and"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"417","published-online":{"date-parts":[[2017,2,1]]},"reference":[{"issue":"1","key":"2021121021424212300_B1","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1136\/adc.87.1.45","article-title":"Cushing\u2019s syndrome, growth impairment, and occult adrenal suppression associated with intranasal steroids.","volume":"87","author":"Perry","year":"2002","journal-title":"Arch Dis Child"},{"issue":"3","key":"2021121021424212300_B2","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s12020-010-9393-6","article-title":"Exogenous Cushing\u2019s syndrome due to topical corticosteroid application: case report and review literature.","volume":"38","author":"Tempark","year":"2010","journal-title":"Endocrine"},{"issue":"11","key":"2021121021424212300_B3","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/nrendo.2013.183","article-title":"Glucocorticoid sensitivity in health and disease.","volume":"9","author":"Quax","year":"2013","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"2021121021424212300_B4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.steroids.2009.09.002","article-title":"The human glucocorticoid receptor: molecular basis of biologic function.","volume":"75","author":"Nicolaides","year":"2010","journal-title":"Steroids"},{"issue":"2","key":"2021121021424212300_B5","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1210\/jc.2003-031148","article-title":"Common polymorphisms in the glucocorticoid receptor gene are associated with adrenocortical responses to psychosocial stress.","volume":"89","author":"W\u00fcst","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2021121021424212300_B6","doi-asserted-by":"crossref","first-page":"4963","DOI":"10.1210\/jc.2008-0892","article-title":"A novel point mutation in the amino terminal domain of the human glucocorticoid receptor (hGR) gene enhancing hGR-mediated gene expression.","volume":"93","author":"Charmandari","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2021121021424212300_B7","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2165\/00002018-200225010-00004","article-title":"Locally administered ocular corticosteroids: benefits and risks.","volume":"25","author":"McGhee","year":"2002","journal-title":"Drug Saf"},{"issue":"2","key":"2021121021424212300_B8","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1001\/archopht.1968.03850040176013","article-title":"Systemic absorption of topical steroids.","volume":"79","author":"Burch","year":"1968","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"2021121021424212300_B9","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S0002-9394(00)00501-8","article-title":"Systemic toxicity of topical and periocular corticosteroid therapy in an 11-year-old male with posterior uveitis.","volume":"130","author":"Ozerdem","year":"2000","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"2021121021424212300_B10","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3928\/0191-3913-20010501-13","article-title":"Adrenal suppression and growth retardation from ocular corticosteroids.","volume":"38","author":"Steelman","year":"2001","journal-title":"J Pediatr Ophthalmol Strabismus"},{"key":"2021121021424212300_B11","doi-asserted-by":"crossref","DOI":"10.1136\/bcr.11.2008.1224","article-title":"Iatrogenic Cushing syndrome caused by ocular glucocorticoids in a child.","volume":"2009","author":"Messina","year":"2009","journal-title":"BMJ Case Rep"},{"issue":"3","key":"2021121021424212300_B12","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00431-014-2477-1","article-title":"Cushing syndrome after bilateral lensectomy.","volume":"174","author":"Scherrer","year":"2015","journal-title":"Eur J Pediatr"},{"issue":"5","key":"2021121021424212300_B13","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.jaci.2013.09.007","article-title":"The biology of the glucocorticoid receptor: new signaling mechanisms in health and disease.","volume":"132","author":"Oakley","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"2021121021424212300_B14","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1749-6632.2009.05013.x","article-title":"Clinical features associated with glucocorticoid receptor polymorphisms. An overview.","volume":"1179","author":"Manenschijn","year":"2009","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"2021121021424212300_B15","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.gde.2012.12.004","article-title":"Regulation and dysregulation of 3'UTR-mediated translational control.","volume":"23","author":"Jia","year":"2013","journal-title":"Curr Opin Genet Dev"},{"issue":"7","key":"2021121021424212300_B16","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.4049\/jimmunol.1500756","article-title":"Translating the untranslated region.","volume":"195","author":"Schwerk","year":"2015","journal-title":"J Immunol"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2016-1233\/1061359\/peds_20161233.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2016-1233\/1061359\/peds_20161233.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,11]],"date-time":"2021-12-11T07:09:30Z","timestamp":1639206570000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/139\/2\/e20161233\/60171\/Iatrogenic-Cushing-s-Syndrome-Due-to-Topical"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,1]]},"references-count":16,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2017,2,1]]},"published-print":{"date-parts":[[2017,2,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2016-1233","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,1]]},"article-number":"e20161233"}}